Blockade of supraspinal 5-HT1A receptors potentiates the inhibitory effect of venlafaxine on wind-up activity in mononeuropathic rats

Brain Res. 2004 May 22;1008(2):288-92. doi: 10.1016/j.brainres.2004.02.041.

Abstract

In mononeuropathic rats submitted to a C-fiber reflex responses paradigm, repeated administration (five successive injections every half-life) of 10 mg/kg, s.c. of venlafaxine, but not of 2.5 mg/kg, s.c., a mixed monoamine reuptake inhibitor with preferential inhibitory activity in 5-HT reuptake, induced a progressive reduction of spinal wind-up. Repeated co-administration of the selective 5-HT1A receptor antagonist WAY 100,635 i.c.v. (50 microg/injection) significantly increased the effect of venlafaxine s.c., indicating that venlafaxine-induced inhibition of spinal wind-up in mononeuropathic rats is potentiated by blockade of central 5-HT1A receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cyclohexanols / pharmacology*
  • Male
  • Nerve Fibers, Unmyelinated / drug effects
  • Peripheral Nervous System Diseases / pathology*
  • Piperazines / pharmacology
  • Pyridines / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Serotonin, 5-HT1A / drug effects*
  • Reflex / drug effects
  • Selective Serotonin Reuptake Inhibitors / pharmacology*
  • Serotonin Antagonists / pharmacology
  • Spinal Cord / cytology*
  • Spinal Cord / drug effects
  • Venlafaxine Hydrochloride

Substances

  • Cyclohexanols
  • Piperazines
  • Pyridines
  • Serotonin Antagonists
  • Serotonin Uptake Inhibitors
  • Receptor, Serotonin, 5-HT1A
  • N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide
  • Venlafaxine Hydrochloride